BOSTON — Two Boston hospitals have been gifted $50 million each by Rob and Karen Hale and the Hale family as of the announcement made on Jan. 22, 2018. The generous gifts were given to the Brigham and Women’s Hospital (BWH) and the Boston Children’s Hospital (BCH) to support cutting-edge innovation and care at both facilities, according to the Hale Family.
Karen and Rob Hale are prominent Boston-area philanthropists, and both serve on the Trust Board for Boston Children’s and have chaired numerous fundraising events for BWH. Karen serves on BWH’s Cancer Research and Care Advisory Board and Rob serves as a chair of BWH’s $1.5 billion “Life.Giving.Breakthroughs” campaign, as well as on the Steering Committee for BCH’s “Dream, Dare, Deliver” campaign.
“Having seen devastating diseases directly touch many of our family members and friends, we’re committed to finding cures and helping more patients walk away with a victory,” said Karen Hale in a recent statement.
In recognition of the Hales’ gift, BWH will name its recently opened building ‘The Hale Building for Transformative Medicine.’ The building houses the Ann Romney Center for Neurologic Diseases; the Evergrande Center for Immunologic Diseases; The Gillian Reny Stepping Strong Center for Trauma Innovation; The Neurosciences Center; the Orthopaedics and Arthritis Center, the Brigham Innovation Hub and the Translational Accelerator. The building also houses an infusion suite and imaging center featuring some of the most powerful and precise technologies in the world.
BCH will name their future 11-story clinical building in honor of the Hales’ remarkable gift. The new building will include a comprehensive and integrated five-floor heart center with a state-of-the-art NICU with 30 beds. In addition, the new building will provide expanded surgical space that includes 10 new operating rooms adjacent to 12 renovated operating rooms.
“Karen and I see Boston as an epicenter for far-reaching medical advances,” Rob Hale in a recent statement. “Both Boston Children’s and the Brigham are international leaders in their research and understanding of diseases. With our $100 million investment in these two world-class institutions, we hope to impact millions of patients.”